ArticlePlastic and reconstructive surgery. Global open2025
Evaluation of Biodegradable Temporizing Matrix for Functional and Aesthetic Outcomes in Hand Soft-tissue Defect: A 3-year Retrospective Study.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Two-stage Reconstruction of Acute Extensive Third-degree Burn Using Biodegradable Temporizing Matrix (NovoSorb BTM).Plastic and reconstructive surgery. Global open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hand soft-tissue defects compromise both function and aesthetics, significantly impacting quality of life. Traditional reconstructive techniques frequently lead to complications, such as donor-site morbidity and suboptimal aesthetic outcomes. The NovoSorb biodegradable temporizing matrix (BTM) may address these challenges by promoting tissue ingrowth. This study evaluates BTM's effectiveness in managing hand soft-tissue defects. Methods: A retrospective cohort study was conducted on 67 patients who underwent BTM placement for hand soft-tissue defects from July 2020 to May 2024. Data were collected on patients' demographics, wound size, cause of injury, time to tissue integration, postoperative complications, and clinical outcomes. Functional outcomes were assessed using range of motion and grip strength, whereas aesthetic outcomes were evaluated using the Patient and Observer Scar Assessment Scale (POSAS). Descriptive and correlational analyses explored the relationship between wound size, return to work, and outcomes. Results: Among the 67 patients (58 men, 9 women; mean age 43.3 y), 97% achieved successful BTM integration, with only 2 cases of failure due to poor vascularity. The mean range of motion for metacarpophalangeal joints was 76.17 degrees, and grip strength averaged 21.3 kg. Functional outcomes, based on the Finger Injury Outcome Score, were good to excellent in 58.2% of cases. Aesthetic outcomes were generally favorable, with a mean POSAS observer score of 3.58. The correlation between wound size and return to work was weak (r = 0.132). Conclusions: NovoSorb BTM appears to be a promising alternative for managing complex hand injuries, providing both functional and aesthetic benefits with minimal complications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.